Hansa Biopharma AB(DE:24H)
€3.95-0.00 (-0.05%)
DE:24H
Hansa Biopharma AB financials statements
€3.95
At close:-0.00 (-0.05%)
Hansa Biopharma AB (24H) Income Statement
8 Followers
Hansa Biopharma AB Income Statement
Last quarter (Q3 2026), Hansa Biopharma AB's total revenue was kr142.99M, an increase of 364.18% from the same quarter last year. In Q3, Hansa Biopharma AB's net income was kr-178.48M. See Hansa Biopharma AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 222.26M | kr 171.32M | kr 134.09M | kr 154.53M | kr 33.88M | |
| kr 138.71M | kr 87.76M | kr 70.95M | kr 116.05M | kr 18.45M | |
| kr 659.42M | kr 725.64M | kr 859.45M | kr 692.17M | kr 558.03M | |
| Depreciation and Amortization | kr 38.76M | kr 28.06M | kr 19.79M | kr 12.05M | kr 8.61M |
| kr -483.82M | kr -642.07M | kr -705.50M | kr -554.26M | kr -538.83M | |
| kr -520.71M | kr -637.88M | kr -788.50M | kr -576.12M | kr -539.58M | |
| kr -9.27M | kr -166.33M | kr -42.32M | kr -33.86M | kr -1.15M | |
| kr -531.84M | kr -804.21M | kr -830.81M | kr -609.98M | kr -548.13M | |
| kr -534.11M | kr -807.24M | kr -831.72M | kr -611.13M | kr -548.28M | |
| Per Share Metrics | |||||
| Basic EPS | kr -6.52 | kr -12.84 | kr -15.83 | kr -13.60 | kr -12.33 |
| Diluted EPS | kr -6.52 | kr -12.84 | kr -15.83 | kr -13.60 | kr -12.33 |
| Weighted Average Shares Outstanding | 81.20M | 62.83M | 52.54M | 44.92M | 44.47M |
| Weighted Average Shares Outstanding (Diluted) | 81.20M | 62.83M | 52.54M | 44.92M | 44.47M |
Currency in SEK
